Ozempic coverage criteria, tier placement, and PA requirements are set at the state PDL level and can differ meaningfully between Michigan, California, Ohio, Texas, and other Molina Medicaid states
Once the appropriate dose is achieved, TSH should be reassessed after 4 to 6 months and then monitored every 12 months [75]
Current therapeutic approaches target IR, hepatic lipid accumulation, and inflammation, yet optimal pharmacological interventions remain under investigation
This mechanism is shared across all GLP-1 drugs, from semaglutide to tirzepatide to retatrutide (PMC12992036)
This contributes to the greater acceptance of GLP-1RAs in patients with type 2 diabetes mellitus or obesity
Acknowledgements D.J.D